The impact of ventilator-associated pneumonia on the Canadian health care system

Journal of Critical Care

Volumn 23, Issue 1, 2008, Pages 5-10

  Muscedere, John G ^a   Martin, Claudio M ^b   Heyland, Daren K ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Canadian health care system; Nosocomial infections; Ventilator associated pneumonia

Indexed keywords

CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; LEVOFLOXACIN; MEROPENEM; VANCOMYCIN;

ARTICLE; ARTIFICIAL VENTILATION; CONFIDENCE INTERVAL; ERADICATION THERAPY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; METHODOLOGY; MORTALITY; REIMBURSEMENT; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; CANADA; CRITICAL ILLNESS; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 40849100127     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2007.11.012     Document Type: Article

References (54)

1. Weinstein R.A. Nosocomial infection update. Emerg Infect Dis 4 3 (1998). http://www.cdc.gov/ncidod/eid/vol4no3/weinstein.htm
2. Guidelines for the prevention of nosocomial pneumonia. Morb Mort Wkly Rep Recomm Rep 46 (1997) 1-79
3. Safdar N., Dezfulian C., Collard H., et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 33 (2005) 2184-2193
4. Safer Health Care Now. http://www.saferhealthcarenow.ca
5. http://www.qualityhealthcarenetwork.ca
6. http://scholar.google.com/
7. http://www.thoracic.org
8. http://www.sccm.org
9. Noseworthy T.W., Konopad E., Shustack A., et al. Cost accounting of adult intensive care: methods and human and capital inputs. Crit Care Med 24 (1996) 1168-1172
10. Ontario Case Cost Methodology for the daily cost of an ICU bed.
11. The Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355 (2006) 2619-2630
12. http://www.statcan.ca
13. Cook D.J., Walter S.D., Cook R.J., et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 129 (1998) 433
14. Baxter A., Allan J., Bedard J., et al. Adherence to simple and effective measure reduces the incidence of ventilator associated pneumonia. Can J Anaesthesia 52 (2005) 535
15. Zuege D., Laupland K., Boiteau P., et al. Etiology of ventilator associated pneumonia in a population-based intensive care unit cohort. Am J Respir Crit Care Med 167 7 (2003) A266
16. Davis L, McRitchie D, Badeau C, et al. Some of the hundred thousand lives saved. CHICA (Community and Hospital Infection Control Association - Canada) in Winnipeg; 2005.
17. Kingston General Hospital, Kingston, Ontario Canada, VAP Surveillance data, Personal communication; 2004.
18. St. Paul's Hospital, Vancouver, British Columbia, Canada. VAP Surveillance data (2005). http://www.providencehealthcare.org
19. Calgary Health Region, VAP surveillance data, 2005, Personal communication.
20. Needham D., Bronskill S., Sibbald W., et al. Mechanical ventilation in Ontario, 1992-2000: incidence, survival, and hospital bed utilization of noncardiac surgery adult patients. Crit Care Med 32 7 (2004) 1504-1509
21. Rapoport J., Teres D., Barnett R., et al. A comparison of intensive care unit utilization in Alberta and western Massachusetts. Crit Care Med 23 (1995) 1336-1346
22. Heyland D.K., Cook D.J., Griffith L., et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Resp Crit Care Med 159 (1999) 1249-1256
23. Ontario Critical Care Inventory. Incidence of ICU beds capable of mechanical ventilation was 8.3 beds/100,000 population (2006). http://www.health.gov.on.ca/english/providers/program/critical_care/docs/report_cc_inventory.pdf
24. Rahim M.T., Milbrandt E.B., Dremsizov T.T., et al. Pricing critical care: an updated Russell equation [abstract]. Crit Care Med Suppl 1 (2004) P76
25. Nseir S., Di Pompeo C., Soubrier S., et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 128 (2005) 1650-1656
26. Rincon-Ferrari M.D., Flores-Cordero J.M., Leal-Noval S.R., et al. Impact of ventilator-associated pneumonia in patients with severe head injury. J Trauma 57 (2004) 1234-1240
27. Rello J., Ollendorf D.A., Oster G., et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122 (2002) 2115-2121
28. Shorr A.F., and O'Malley P.G. Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia: potential economic implications. Chest 119 (2001) 228-235
29. Warren D.K., Shukla S.J., Olsen M.A., et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 5 (2003) 1312-1317
30. Cocanour C.S., Peninger M., Domonoske B.D., et al. Decreasing ventilator-associated pneumonia in a trauma ICU. J Trauma 61 (2006) 122-129
31. Bregeon F., Ciais V., Carret V., et al. Is ventilator-associated pneumonia an independent risk factor for death?. Anesthesiology 94 (2001) 554-560
32. Moreno C.A., Rosenthal V.D., Olarte N., et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 27 (2006) 349-356
33. Leroy O., Guilley J., Georges H., et al. Effect of hospital-acquired ventilator-associated pneumonia on mortality of severe community-acquired pneumonia. J Crit Care 14 (1999) 12-19
34. Crouch Brewer S., Wunderink R.G., Jones C.B., et al. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 109 (1996) 1019-1029
35. Mehta R.M., and Niederman M.S. Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. J Intensive Care Med 18 (2003) 175-188
36. Miller A., Hyland M., Ofner-Agostini M., et al. The Canadian Nosocomial Infection Surveillance Program. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 23 (2002) 137-140
37. Louie T. Clostridium difficile in clinical practice: increasing rates, more virulent organisms and new therapies on the horizon. Can J Infect Dis Med Microbiol 17 Suppl B (2006) 19B-24B
38. HIV and AIDS in Canada, Surveillance report to June 2004. http://www.phac-aspc.gc.ca/publicat/aids-sida/haic-vsac0604/index.html
39. Canadian Motor Vehicle Traffic Collision Statistics. Transp Can (2001). http://www.tc.gc.ca/roadsafety/tp/tp3322/2001/menu.htm
40. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
41. Carson S., Cox C., Holmes T., et al. The changing epidemiology of mechanical ventilation: a population-based study. J Intensive Care Med 21 3 (2006) 173-182
42. Needham D.M., Bronskill S.E., Calinawan J.R., et al. Projected incidence of mechanical ventilation in Ontario to 2026: preparing for the aging baby boomers. Crit Care Med 33 (2005) 574-579
43. Tejerina E., Frutos-Vivar F., Restrepo M.I., et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 21 (2006) 56-65
44. Cocanour C.S., Ostrosky-Zeichner L., Peninger M., et al. Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit. Surg Infect 6 (2005) 65-72
45. Health Canada. The economic burden of illness in Canada. http://www.hc-sc.gc.ca
46. Dodek P., Keenan S., Cook D., et al. Evidence based clinical based guideline for the prevention of ventilator associated pneumonia. Ann Intern Med 141 (2004) 305-313
47. Heyland D.K., Cook D.J., and Dodek P.M. Prevention of ventilator associated pneumonia: current practice in Canadian intensive care units. J Crit Care 17 (2002) 161-167
48. Muscedere J., Heyland D.K., Dodek P., et al. The prevention of ventilator associated pneumonia in Canadian critical care units. Presented at Toronto Critical Care Medicine Symposium, October (2005)
49. Zack J., Garrison T., Trovillon E., et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 30 (2002) 2407-2412
50. Kelleghan S.I., Salemi C., Padilla S., et al. An effective continuous quality improvement approach to the prevention of ventilator-associated pneumonia. Am J Infect Control 21 (1993) 322-330
51. Salahuddin N., Zafarb A., Sukhyanic L., et al. Reducing ventilator-associated pneumonia rates through a staff education programme. J Hosp Infection 57 (2004) 223-227
52. Babcock H., Zack J., Garison T., et al. An educational intervention to reduce ventilator associated pneumonia in an integrated health system: a comparison of effects. Chest 125 (2004) 2224-2231
53. http://www.ihi.org/IHI/Programs/Campaign/
54. ABATE VAP, clinicaltrials.gov.